Hookipa Pharma Correlations

HOOK Stock

USD 1.25 0.02 1.63%

The current 90-days correlation between Hookipa Pharma and Amylyx Pharmaceuticals is 0.13 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hookipa Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hookipa Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Hookipa Pharma Correlation With Market

Significant diversification

The correlation between Hookipa Pharma and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Moving together with Hookipa Stock

0.75	MOLN	Molecular Partners	Pair Corr
0.77	SNDL	SNDL Inc	Pair Corr
0.83	CLDX	Celldex Therapeutics	Pair Corr
0.61	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.62	CRVS	Corvus Pharmaceuticals	Pair Corr
0.71	ELMD	Electromed	Pair Corr
0.9	GKOS	Glaukos Corp	Pair Corr
0.66	INGN	Inogen Inc	Pair Corr
0.86	ITGR	Integer Holdings Corp	Pair Corr
0.92	LIVN	LivaNova PLC	Pair Corr
0.87	MODD	Modular Medical	Pair Corr
0.87	APYX	Apyx Medical	Pair Corr
0.89	SRDX	SurModics	Pair Corr
0.83	CNMD	CONMED	Pair Corr
0.61	RKV	Rakovina Therapeutics	Pair Corr

Moving against Hookipa Stock

0.92	CMRX	Chimerix Sell-off Trend	Pair Corr
0.76	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.62	FNA	Paragon 28	Pair Corr
0.72	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.65	LUNG	Pulmonx Corp	Pair Corr
0.65	NVRO	Nevro Corp	Pair Corr
0.58	INMD	InMode	Pair Corr
0.35	NYXH	Nyxoah	Pair Corr
0.88	NHNCF	NAVER Corp	Pair Corr
0.85	BRK-A	Berkshire Hathaway	Pair Corr
0.85	BRK-B	Berkshire Hathaway	Pair Corr
0.73	PKX	POSCO Holdings	Pair Corr
0.69	FWEDF	Fireweed Zinc	Pair Corr
0.43	TRGGF	Tarachi Gold Corp	Pair Corr

Related Correlations Analysis

	MREO	TERN	PDSB	INZY	DAWN	ELDN	XFOR	ABOS	AMLX
MREO		0.9	0.81	0.9	0.73	0.5	0.86	0.89	0.64	MREO
TERN	0.9		0.9	0.93	0.74	0.51	0.83	0.95	0.68	TERN
PDSB	0.81	0.9		0.83	0.7	0.58	0.83	0.89	0.68	PDSB
INZY	0.9	0.93	0.83		0.58	0.37	0.81	0.87	0.71	INZY
DAWN	0.73	0.74	0.7	0.58		0.79	0.8	0.77	0.3	DAWN
ELDN	0.5	0.51	0.58	0.37	0.79		0.67	0.49	0.22	ELDN
XFOR	0.86	0.83	0.83	0.81	0.8	0.67		0.82	0.5	XFOR
ABOS	0.89	0.95	0.89	0.87	0.77	0.49	0.82		0.63	ABOS
AMLX	0.64	0.68	0.68	0.71	0.3	0.22	0.5	0.63		AMLX
	MREO	TERN	PDSB	INZY	DAWN	ELDN	XFOR	ABOS	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Hookipa Stock performing well and Hookipa Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hookipa Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
MREO	2.57	(0.46)	(0.68)	6.16	(6.13)	20.77
TERN	2.99	(0.99)	(1.29)	4.94	(6.98)	19.13
PDSB	4.57	(0.28)	(0.45)	9.21	(9.22)	33.91
INZY	4.06	(1.42)	(0.90)	6.82	(9.17)	36.29
DAWN	2.86	(0.51)	(0.63)	6.36	(6.67)	22.86
ELDN	2.71	(0.21)	(0.22)	4.71	(5.28)	18.63
XFOR	6.40	(0.54)	(1.69)	11.67	(13.51)	68.45
ABOS	2.97	(0.69)	(0.63)	6.57	(7.09)	19.77
AMLX	3.72	(0.05)	(0.11)	7.20	(9.09)	21.45

Hookipa Pharma Corporate Management

Lukas Flatz	CoFounder	Profile
Klaus Orlinger	Chief Officer	Profile
Reinhard Kandera	CFO Director	Profile
Matthew Beck	Executive Relations	Profile
Mark Winderlich	Chief Officer	Profile
Joern Aldag	CEO Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC